Neural Therapeutics Inc.' Scientific Advisor Professor David Nutt answers questions raised by his recent presentation on the potentially revolutionary untapped effects of psychedelic medicine
The presentation focused on what Professor Nutt describes as the utility of psychedelic compounds and their potential to transform the treatment of mental illness.
Today's questions asks: "Do we really need more types of drug therapy when we already have ketamine clinics/therapy?"
Neural Therapeutics is a drug-discovery company focusing on plant-based active substances with the goal of delivering beneficial, over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments where no significant treatment is available today.